P670: A collaborative model integrating clinical genetics and molecular pathology for tumor/normal paired whole exome sequencing testing
Yi Liu(Ewha Womans University), Kenneth Aldape(National Institutes of Health), Grace‐Ann Fasaye(National Institutes of Health), Mark Raffeld(National Cancer Institute), Frederic G. Barr(National Institutes of Health), Ina Lee(National Institutes of Health), Christina K. Ferrone(National Cancer Institute), Alexandra Lebensohn(National Institutes of Health), Liqiang Xi(Center for Cancer Research), Manoj Tyagi(National Institutes of Health), Margarita Raygada, Antonios Papanicolau‐Sengos(National Institutes of Health), Chimene Kesserwan(National Cancer Institute), Hermi Mesfin(Cancer Institute (WIA)), Stephen M. Hewitt(National Institutes of Health), Jung Kim(Yale University), Svetlana Pack(National Cancer Institute)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k